The relationship of COX-2 expression with estrogen receptor, progesterone receptor and prognostic parameters in endometrial carcinomas

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 3, 2010, Pages 560-566

  Keser, Sevinç Hallaç ^a   Gül, Aylin Ege ^a   Barişik, Nagehan Özdemir ^a   Çakir, Çaǧlar ^a   Şensu, Sibel ^a   Kandemir, Nilüfer Onak ^a   Karadayi, Nimet ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

COX 2; Endometrial carcinoma; Estrogen receptor; Progesterone receptor

Indexed keywords

CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MENSTRUATION; PROGNOSIS; UTERUS DISEASE; CARCINOMA; ENDOMETRIUM TUMOR; METABOLISM; PATHOLOGY;

CARCINOMA; CYCLOOXYGENASE 2; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 77953351147     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01179.x     Document Type: Article

References (24)

1. Ferrandina G, Ranelletti FO, Gallotta V et al. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Gynecol Oncol 2005 98 : 383 389.
2. Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: A hypothesis. Cancer Epidemiol Biomarkers Prev 2005 14 : 2840 2847.
3. Sugimoto T, Koizumi T, Sudo T et al. Correlative expression of cyclooxygenase -1 (COX-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer. Kobe J Med Sci 2007 53 : 177 187.
4. Arango HA, Icely S, Robert WS, Cavanagh D, Becker JL. Aspirin effects on endometrial cancer cell growth. Obstet Gynecol 2001 97 : 423 427.
5. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: From a phenotypical to a molecular-based classification. Virchows Arch 2004 444 : 213 223.
6. Sherbet GV, Patil D. Genetic abnormalities of cell proliferation, invasion and metastasis, with special reference to gynaecological cancers. Anticancer Res 2003 23 : 1357 1371.
7. Jeon YT, Kang S, Kang DH et al. Cyclooxygenase-2 and p53 expressions in endometrial cancer. Cancer Epidemiol Biomarkers Prev 2004 13 : 1538 1542.
8. Tong BJ, Tan J, Tajeda L et al. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-in human endometrial adenocarcinoma. Neoplasia 2000 2 : 483 490.
9. Munkarah A, Ali-Fehmi R. COX-2: A protein with an active role in gynecological cancers. Curr Opin Obstet Gynecol 2005 17 : 49 53.
10. Tamura M, Sebastian S, Yang S et al. Up-regulation of cylooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. J Biol Chem 2002 277 : 26208 26216.
11. Cao QJ, Einstein MH, Anderson PS, Runowicz CD, Balan R, Jones JG. Expression of COX-2, Ki-67, cyclin D1, and p21 in endometrial endometrioid carcinomas. Int J Gynecol Pathol 2002 21 : 147 154.
12. Kanayama S, Yamada Y, Kawaguchi R, Tsuji Y, Haruta S, Kobayashi H. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells. Oncology Reports 2008 19 : 117 122.
13. Fowler JM, Ramirez N, Cohn DE et al. Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: Tissue microarray analysis. Am J Obstet Gynecol 2005 192 : 1262 1273.
14. Li W, Xu RJ, Zhang HH, Jiang LH. Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. Int Gynecol Cancer 2006 16 : 1673 1678.
15. Landen CN, Mathur SP, Richardson MS, Creasman WT. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol 2003 188 : 1174 1176.
16. Horn LC, Faber S, Bilek K, Leo C. Expression of COX-2 and HER-2/neu and estrogen and progesterone receptor in primary squamous cell carcinomas of the endometrium. J Cancer Res Clin Oncol 2005 131 : 226 228.
17. Genç S, Attar E, Gürdöl F, Kendigelen S, Bilir A, Serdaroǧlu H. The effect of COX-2 inhibitor, nimesulide, on angiogenetic factors in primary endometrial carcinoma cell culture. Clin Exp Med 2007 7 : 6 10.
18. Orejuela FJ, Ramondetta LM, Smith J et al. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Gynecol Oncol 2005 97 : 483 488.
19. Erkanli S, Bolat F, Kayaselcuk F, Demirhan B, Kuscu E. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma. Gynecol Oncol 2007 104 : 320 325.
20. Ohno Y, Ohno S, Suzuki N et al. Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma. Int J Cancer 2005 114 : 696 701.
21. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW. Immunohistochemical profile of endometrial adenocarcinoma: A study of 61 cases and review of the literature. Mod Pathol 2000 13 : 379 388.
22. Ferrandina G, Legge F, Ranelletti FO et al. Cyclooxygenase-2 expression in endometrial carcinoma. Correlation with clinicopathologic parameters and clinical outcome. Cancer 2002 95 : 801 807.
23. Fujiwaki R, Iida K, Kanasaki H, Ozaki T, Hata K, Miyazaki K. Cyclooxygenase-2 expression in endometrial cancer: Correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Hum Pathol 2002 33 : 213 219.
24. Steinbache G, Lynch PM, Phillips RK et al. The effect of celecoxib, a cyclooxigenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000 342 : 1946 1952.